0
Soleno Therapeutics, Inc. Banner Image

Soleno Therapeutics, Inc.

  • Ticker SLNO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Soleno Therapeutics, Inc. Logo Image
  • 1-10 Employees
  • Based in Redwood City, California
Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, Diazoxide Choline Controlled-Release (DCCR) tablets, a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is currently being evaluated in a Phase III clinical development program.
Soleno Therapeutics, Inc.

Most Recent Annual Report

Soleno Therapeutics, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports